Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kengo Furuichi

Showing results (1-10 of 207) with videos related to

Pageof 21
Sort By:
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|July 17, 2014
[Acute kidney injury: progress in diagnosis and treatments. Topics: IV. Pathophysiology and treatments; 3. Drug induced AKI]Kengo Furuichi, Takashi Wada
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|January 19, 2012
[Update information for physicians on laboratory tests: recent progress in clinical laboratory testing. Topics: II. Particulars with special emphasis on novel laboratory tests; 5. Kidney and urinary tract disease]Takashi Wada, Kengo Furuichi
Kidney360|February 29, 2024
D-Amino Acids in Kidney DiseasesKengo Furuichi, Yasunori Iwata
Nihon Jinzo Gakkai Shi|May 13, 2016
[Clinical and pathological features of nephrosclerosis]Kengo Furuichi, Takashi Wada
Contributions to Nephrology|July 25, 2018
Apheresis for Kidney DiseaseKengo Furuichi, Takashi Wada
Clinical and Experimental Nephrology|December 17, 2008
Chemokine/chemokine receptor-mediated inflammation regulates pathologic changes from acute kidney injury to chronic kidney diseaseKengo Furuichi, Shuichi Kaneko, Takashi Wada
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|June 5, 2004
[Advances in the treatment of progressive renal dysfunctions. 7. Immunosuppressive agents used to treat renal dysfunctions and their indication]Hitoshi Yokoyama, Takashi Wada, Kengo Furuichi
Nihon Jinzo Gakkai Shi|December 3, 2013
[Impact of dyslipidemia on the onset and progression of diabetic complications]Shinji Kitajima, Kengo Furuichi, Takashi Wada
Nihon Jinzo Gakkai Shi|December 15, 2018
Epidemiology and pathogenesis of diabetic nephropathyMiho Shimizu, Kengo Furuichi, Takashi Wada
Kidney International|August 14, 2016
Inhibition of NLRP3 inflammasome as a therapeutic intervention in crystal-induced nephropathyNorihiko Sakai, Kengo Furuichi, Takashi Wada
Pageof 21

Showing results (1-10 of 207) with videos related to

Sort By:
Pageof 21
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|July 17, 2014
[Acute kidney injury: progress in diagnosis and treatments. Topics: IV. Pathophysiology and treatments; 3. Drug induced AKI]Kengo Furuichi, Takashi Wada
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|January 19, 2012
[Update information for physicians on laboratory tests: recent progress in clinical laboratory testing. Topics: II. Particulars with special emphasis on novel laboratory tests; 5. Kidney and urinary tract disease]Takashi Wada, Kengo Furuichi
Kidney360|February 29, 2024
D-Amino Acids in Kidney DiseasesKengo Furuichi, Yasunori Iwata
Nihon Jinzo Gakkai Shi|May 13, 2016
[Clinical and pathological features of nephrosclerosis]Kengo Furuichi, Takashi Wada
Contributions to Nephrology|July 25, 2018
Apheresis for Kidney DiseaseKengo Furuichi, Takashi Wada
Clinical and Experimental Nephrology|December 17, 2008
Chemokine/chemokine receptor-mediated inflammation regulates pathologic changes from acute kidney injury to chronic kidney diseaseKengo Furuichi, Shuichi Kaneko, Takashi Wada
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|June 5, 2004
[Advances in the treatment of progressive renal dysfunctions. 7. Immunosuppressive agents used to treat renal dysfunctions and their indication]Hitoshi Yokoyama, Takashi Wada, Kengo Furuichi
Nihon Jinzo Gakkai Shi|December 3, 2013
[Impact of dyslipidemia on the onset and progression of diabetic complications]Shinji Kitajima, Kengo Furuichi, Takashi Wada
Nihon Jinzo Gakkai Shi|December 15, 2018
Epidemiology and pathogenesis of diabetic nephropathyMiho Shimizu, Kengo Furuichi, Takashi Wada
Kidney International|August 14, 2016
Inhibition of NLRP3 inflammasome as a therapeutic intervention in crystal-induced nephropathyNorihiko Sakai, Kengo Furuichi, Takashi Wada
Pageof 21